Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease

Mov Disord. 2004 May;19(5):571-9. doi: 10.1002/mds.10714.

Abstract

We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinson's disease (PD; n = 35) and multiple system atrophy (MSA; n = 30). The median CSF concentration of the neurotransmitter metabolites 5-hydroxyindolacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) was reduced significantly (49-70%) in MSA compared to PD. In contrast, several brain-specific proteins (tau, neuron-specific enolase, myelin basic protein) were elevated (130-230%) in MSA compared with those in PD. A combination of CSF tau and MHPG discriminated PD from MSA (adjusted odds ratios: tau, 27.2; MHPG, 0.14). Our data suggest that the more progressive and widespread neurodegenerative nature of MSA, as compared with PD, is reflected in the composition of CSF. We propose that CSF analysis may become part of the diagnostic work-up of patients with parkinsonian syndromes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Benzamides
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Diagnosis, Differential
  • Electromyography
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Homovanillic Acid / cerebrospinal fluid
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Iodine Radioisotopes
  • Lactic Acid / cerebrospinal fluid
  • Male
  • Methoxyhydroxyphenylglycol / cerebrospinal fluid
  • Multiple System Atrophy / cerebrospinal fluid*
  • Multiple System Atrophy / diagnosis*
  • NAD / cerebrospinal fluid
  • Parkinson Disease / cerebrospinal fluid*
  • Parkinson Disease / diagnosis*
  • Pyrrolidines
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed

Substances

  • Benzamides
  • Iodine Radioisotopes
  • Pyrrolidines
  • NAD
  • Lactic Acid
  • Methoxyhydroxyphenylglycol
  • Hydroxyindoleacetic Acid
  • 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
  • Homovanillic Acid